Podcast Episodes
Back to SearchJan 24 2025 This Week in Cardiology
Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discu…
1 year, 5 months ago
Jan 17 2025 This Week in Cardiology
Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon…
1 year, 5 months ago
Jan 10 2025 This Week in Cardiology
Alcohol and cancer, GLP-1 trial representativeness, diagnosing CAD, changing stroke rates in patients with AF, blanking periods after AF ablation are…
1 year, 5 months ago
Dec 20 2024 This Week in Cardiology
Listener feedback, multiple studies in AF ablation,
a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are…
1 year, 6 months ago
Dec 13 2024 This Week in Cardiology
US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA…
1 year, 6 months ago
Dec 06 2024 This Week in Cardiology
Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are th…
1 year, 6 months ago
Nov 22 2024 This Week in Cardiology
An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast…
1 year, 7 months ago
Nov 15 2024 This Week in Cardiology
Tirzepatide, AF screening, and an AHA preview, including VT ablation, LAAC at the time of AF ablation, BP targets, and GLP1 agonists in HF are the to…
1 year, 7 months ago
Nov 08 2024 This Week in Cardiology
The EARLY TAVR trial, colchicine after MI, and the TRISCEND II trial of tricuspid valve replacement are the topics John Mandrola, MD, covers in this …
1 year, 7 months ago
Oct 25 2024 This Week in Cardiology
Listener feedback on PFA and STEMI/NSTEMI paradigm, oral semaglutide, symptomatic vs asymptomatic AF, and the win-ratio are the topics John Mandrola,…
1 year, 8 months ago